FDA Approval for oral contraceptive – teamwork to success SCOPE International AG announces that The US Food and Drug Administration (FDA) has approved the new drug application (NDA) of an oral contraceptive for pregnancy prevention that was developed by one of our clients. SCOPE played a major role throughout the developmental process. The entirety of this [...]
SCOPE International announces successful FDA inspection SCOPE International AG is proud to announce that its subsidiary in the United States, SCOPE International USA, Inc., was successfully inspected by the US Food and Drug Administration in June 2019. The outcome of this FDA inspection is the most recent example of the high-quality results produced by the SCOPE [...]
3-6 May 2019 | ACOG Annual Meeting We are excited to announce that SCOPE International will be attending and exhibiting at The American College of Obstetricians and Gynecologists (ACOG) Annual Conference in Nashville, TN from May 3-5. We welcome you to drop by Booth #450 to learn more about our company and our experience and expertise [...]
